BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 7614459)

  • 1. Telomerase activity in gastric cancer.
    Hiyama E; Yokoyama T; Tatsumoto N; Hiyama K; Imamura Y; Murakami Y; Kodama T; Piatyszek MA; Shay JW; Matsuura Y
    Cancer Res; 1995 Aug; 55(15):3258-62. PubMed ID: 7614459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
    Engelhardt M; Drullinsky P; Guillem J; Moore MA
    Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomerase activity in human bladder cancer.
    Lin Y; Miyamoto H; Fujinami K; Uemura H; Hosaka M; Iwasaki Y; Kubota Y
    Clin Cancer Res; 1996 Jun; 2(6):929-32. PubMed ID: 9816252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of human telomerase catalytic subunit during gastric carcinogenesis.
    Jong HS; Park YI; Kim S; Sohn JH; Kang SH; Song SH; Bang YJ; Kim NK
    Cancer; 1999 Aug; 86(4):559-65. PubMed ID: 10440682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomerase activity and telomere length in lymphocytes from patients with cutaneous T-cell lymphoma.
    Wu K; Lund M; Bang K; Thestrup-Pedersen K
    Cancer; 1999 Sep; 86(6):1056-63. PubMed ID: 10491534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.
    Engelhardt M; Albanell J; Drullinsky P; Han W; Guillem J; Scher HI; Reuter V; Moore MA
    Clin Cancer Res; 1997 Oct; 3(10):1849-57. PubMed ID: 9815573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomerase activity and alterations in telomere length in human brain tumors.
    Hiraga S; Ohnishi T; Izumoto S; Miyahara E; Kanemura Y; Matsumura H; Arita N
    Cancer Res; 1998 May; 58(10):2117-25. PubMed ID: 9605755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomerase activity could be used as a marker for neoplastic transformation in gastric adenocarcinoma: but it does not have a prognostic significance.
    Gümüş-Akay G; Unal AE; Bayar S; Karadayi K; Elhan AH; Sunguroĝlu A; Tükün A
    Genet Mol Res; 2007 Feb; 6(1):41-9. PubMed ID: 17469053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions.
    Tahara H; Kuniyasu H; Yokozaki H; Yasui W; Shay JW; Ide T; Tahara E
    Clin Cancer Res; 1995 Nov; 1(11):1245-51. PubMed ID: 9815918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma.
    Gertler R; Rosenberg R; Stricker D; Friederichs J; Hoos A; Werner M; Ulm K; Holzmann B; Nekarda H; Siewert JR
    J Clin Oncol; 2004 May; 22(10):1807-14. PubMed ID: 15143073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the full-length telomerase reverse transcriptase (hTERT) transcript in both malignant and normal gastric tissues.
    Li W; Li L; Liu Z; Liu C; Liu Z; Strååt K; Björkholm M; Jia J; Xu D
    Cancer Lett; 2008 Feb; 260(1-2):28-36. PubMed ID: 18037230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of telomerase activity and telomere length in bone and soft tissue tumors.
    Terasaki T; Kyo S; Takakura M; Maida Y; Tsuchiya H; Tomita K; Inoue M
    Oncol Rep; 2004 Jun; 11(6):1307-11. PubMed ID: 15138570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase activity in neuroendocrine tumors.
    Bockhorn M; Frilling A; Clauer U; Hertl M; Broelsch CE
    Int J Surg Investig; 2000; 2(3):219-25. PubMed ID: 12678522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High telomerase activity is associated with cell cycle deregulation and rapid progression in endometrioid adenocarcinoma of the uterus.
    Bonatz G; Frahm SO; Klapper W; Helfenstein A; Heidorn K; Jonat W; Krupp G; Parwaresch R; Rudolph P
    Hum Pathol; 2001 Jun; 32(6):605-14. PubMed ID: 11431715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma.
    Garcia-Aranda C; de Juan C; Diaz-Lopez A; Sanchez-Pernaute A; Torres AJ; Diaz-Rubio E; Balibrea JL; Benito M; Iniesta P
    Cancer; 2006 Feb; 106(3):541-51. PubMed ID: 16388518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase activity in ovarian tumors.
    Murakami J; Nagai N; Ohama K; Tahara H; Ide T
    Cancer; 1997 Sep; 80(6):1085-92. PubMed ID: 9305709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of telomerase activity in gastric cancer and adjacent tissues].
    Gao F; Zhang W; Jing S; Liu Y; Zhang B
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Aug; 21(4):298-301. PubMed ID: 12567454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomerase activity in normal and malignant murine tissues.
    Chadeneau C; Siegel P; Harley CB; Muller WJ; Bacchetti S
    Oncogene; 1995 Sep; 11(5):893-8. PubMed ID: 7675448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Telomere length and telomerase activity in intestinal metaplasia, adenoma and well differentiated adenocarcinoma of the stomach].
    Maruyama Y; Hanai H; Kaneko E
    Nihon Rinsho; 1998 May; 56(5):1186-9. PubMed ID: 9613119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High telomerase activity is an independent prognostic indicator of poor outcome in colorectal cancer.
    Tatsumoto N; Hiyama E; Murakami Y; Imamura Y; Shay JW; Matsuura Y; Yokoyama T
    Clin Cancer Res; 2000 Jul; 6(7):2696-701. PubMed ID: 10914712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.